Lenalidomide maintenance after first-line therapy for high-risk chronic lymphocytic leukaemia (CLLM1): final results from a randomised, double-blind, phase 3 study
| Image |  |
|---|---|
| Description | scientific article published on 12 September 2017 |
| Author/s |
author: Barbara Eichhorst Stephan Stilgenbauer Clemens-Martin Wendtner Michael Hallek Hartmut Döhner Jasmin Bahlo Othman Al-Sawaf Paolo Ghia |
| Publication date | September 12, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |